Critical Medicines Act

Inside EU Health: CMA trilogue; cardiovascular strategy; EMA medicines approval; healthcare accessibility

Critical Medicines Act negotiations begin; prevention takes centre stage in opening EU cardiovascular health report; EMA recommends approval of six medicines, expands indications for nine; Eurostat figures show wide gaps in healthcare accessibility across EU

Critical Medicines Act

Critical Medicines Act negotiations begin, with urgency stressed by co-legislators

The kick-off trilogue on the Critical Medicines Act (CMA) took place on Monday (2 February) evening, with discussions described as constructive. Co-legislators reiterated both their readiness to move forward and the urgency of the file, given ongoing concerns around the EU’s security of medicine supply. Earlier that afternoon, addressing

Inside EU Health

Inside EU Health: Parliament votes on Critical Medicines Act; EMA regulatory co-operation; Paracetamol (still) safe during pregnancy

Parliament votes on Critical Medicines Act position; EMA to build on regulatory co-operation piloted under COVID; Paracetamol is (still) safe during pregnancy

Critical Medicines Act

Parliament draws the battle lines on Europe’s Critical Medicines Act

The European Parliament has overwhelmingly endorsed a more ambitious Critical Medicines Act

Inside EU Health

Inside EU Health: Parliament pushes for bolder CMA; cardiovascular disease costs 2% EU GDP; EU backs rapid ‘test-before-treat’ diagnostic

Parliament pushes for a more ambitious and European Critical Medicines Act; report estimates that cardiovascular disease costs the EU 2% of GDP; and Commission backs rapid ‘Test Before Treat’ technology to reduce misuse of antibiotics

Critical Medicines Act

Parliament pushes for a more ambitious and European approach to Critical Medicines Act

The European Parliament’s public health committee has endorsed compromise amendments to the Critical Medicines Act, setting out a more ambitious approach than member states

Inside EU Health

Inside EU Health: Council position on Critical Medicines Act; UK-US deal will removes tariffs; will the GLP-1 manufacturers step up to WHO challenge

Council reaches position on Critical Medicines Act; UK-US deal will increase the cost of drugs but removes tariffs; will the GLP-1 manufacturers step up to WHO challenge

Critical Medicines Act

Council reaches deal on Critical Medicines Act, but level of ambition questioned

EU Ministers backed a joint negotiating position on the Critical Medicines Act agreement, but some consider it a missed opportunity

Inside EU Health

Inside EU Health: Medicine shortages tipping point; WHO forced to slash workforce; stronger guardrails for AI

Medicine shortages tipping point; WHO forced to slash workforce; stronger guardrials for AI

Critical Medicines Act

Urgent action needed to stem critical medicine shortages

Medicines for Europe says study highlights the need for reforms to secure patient access to medicines

Pharma Package

Danes aim to resolve outstanding issues at ‘jumbo’ trilogue in December

The Pharma Package proposed in 2023 may finally be reaching its conclusion

Critical Medicines Act

Critical Medicines Act: Parliament ambition versus Council revision

The Critical Medicines Act receives over a thousand proposed amendments from MEPs - while the Council is determined to weaken its provisions

Competitiveness

Várhelyi sets out his sweeping plans to reshape Europe’s competitiveness in health

EU Health Commissioner Várhelyi has many ambitious plans and a tight schedule

EU/US Trade

EU calms fears as Trump tweet raises alarm on tariffs – but drug-pricing pressure remains

Concern over a tweet threatening to impose 100% tariffs on pharma companies was quickly quelled, but concerns on pricing remains

Critical medicines

Auditors say the EU must strengthen its response to critical medicine shortages

In a special report, published today (17 September), the European Court of Auditors (ECA) warns that critical medicine shortages continue to arise, posing a threat to health across the EU. “Medicine shortages can have severe consequences for patients, compromise public health and come at a high cost for doctors, pharmacies

AMR

Danish Presidency calls for more decisive joint action on antimicrobial resistance

Health ministers recommitted to strengthening their response to antimicrobial resistance, following a call for more action from WHO/Europe Region Director Hans Kluge. At yesterday’s informal Council for EU/EEA health ministers in Copenhagen (16/09), ministers covered a wide range of issues with sessions on life sciences and

Critical Medicines Act

MEPs rally behind Sokol’s report on Critical Medicines

Yesterday afternoon (01/09), the European Parliament’s Health Committee (SANT) discussed MEP Tomislav Sokol’s (EPP, Croatia) report on the Critical Medicines Act. MEPs were supportive of strengthening the proposal to tackle the availability of medicines, addressing the problem of shortages, and making the EU less dependent on external